Advertisement
Screener

GENELUX CORPORATION (GNLX) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

GENELUX CORPORATION (GNLX) Return on Tangible Equity

  • 2026-06-30: Return Tang Equity -220.91%.
  • 2026-03-31: Return Tang Equity -146.51%.
  • 2025-12-31: Return Tang Equity -278.46%.
  • 2025-09-30: Return Tang Equity -171.45%.

Complete source-backed return tang equity history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang Equity
2026-06-30-220.91%
2026-03-31-146.51%
2025-12-31-278.46%
2025-09-30-171.45%
2025-06-30-127.17%
2025-03-31-98.88%
2024-12-31-113.68%
2024-09-30-83.59%
2024-06-30-70.45%
2024-03-31-170.93%
2023-12-31-145.31%
2023-09-30-104.15%
2023-06-30-66.37%
2023-03-31-437.38%
2022-12-3114.55%

Annual Return Tang Equity

DateReturn Tang Equity
2025-12-31-278.46%
2024-12-31-113.68%
2023-12-31-145.31%
2022-12-3114.55%

Similar stocks

Stock NameCountryMarket CapPE Ratio
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
Equillium, Inc. (EQ)United States$0.109B-11.27
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ProMIS Neurosciences Inc. (PMN)$0.102B
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95